Pharma
How content marketing is transforming scientific sales strategies
Learn how science and biotech marketers can boost qualified leads, increase sales, and build trust by using data-driven content marketing and AI-powered lead nurturing strategies. ...
Harnessing population health strategies to transform ILD outcomes
Interstitial lung diseases (ILDs) represent a diverse group of over 200 chronic respiratory conditions characterised by varying degrees of inflammation and fibrosis of the lung tissue. They include conditions such as idiopathic pulmonary fibrosis (IPF), connective tissue disease-associa...
Guardtech Group streamlining cleanroom furniture & equipment fit-outs with Guardware ISO range
The Suffolk-based controlled environment construction specialists recently launched a new website dedicated to their cleanroom hardware brand which offers a revolutionary customer experience ...
CamAWiSE event roundup: October 8th 2025, Intentional Careers - taking control of your career with Hannah Roberts
This was the first of our online series of three webinars exploring the overarching theme of "Career Resilience in a Changing World". Dr Vince Pizzoni is running the next in our trio of workshops entitled "Building Bridges Through the Power of Supportive Networks" - look at our events s...
Practical IT Security at Silverstone
JOIN our action packed fun day out at Silverstone, home of British Motorsport... and get some critical food for thought to apply to your own IT Security. Responsible for IT decisions at a business with around 20-300 staff? (Using or considering using Microsoft 365.) This event is desi...
Qureight’s Vascul8 model validated to improve care for pulmonary vascular disorders
Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas for severe respiratory diseaseData demonstrate sensitive quantification of vascular rem...
BioBeat: Launching the next chapter
BioBeat is joining the One Nucleus hub for life science innovation Cambridge, UK: 23 October 2025The exciting new chapter for BioBeat begins with One Nucleus! BioBeat, connecting entrepreneurs with biotech leaders, is joining the One Nucleus hub for life science innovation. On...
Redefining drug discovery with NAMs: Medicilon’s AI-driven NAMs platform
In April 2025, the US FDA began phasing out mandatory animal testing for monoclonal antibodies and biologic drugs, a landmark decision that officially brings New Approach Methodologies (NAMs) into the global R&D spotlight. ...
Mosaic Therapeutics appoints Thomas Fuchs as CEO
Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadershipAppointment strengthens executive leadership team and supports transition into clinical developmentCambridge, UK, 20 October ...
CONEXEN Cambridge December
A warm and welcoming community for professionals and founders in biopharma, life sciences, and health tech in Cambridge! Here, we invite you to join us for an informal and friendly gathering where connections are made, knowledge is shared, and friendships are formed. Come with an open h...